Baotou Dongbao Bio-Tech Co.,Ltd
300239.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.29B
Close$
$2.09
60.1% downside
Current Fair Value
60.1% downsideOvervalued by 60.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.29 Billion |
|---|---|
| Enterprise Value | $3.35 Billion |
| Dividend Yield | $0.01 (0.22%) |
| Earnings per Share | $0.09 |
| Beta | 0.16 |
| Outstanding Shares | 583,049,765 |
Return
| Return on Equity | 3.12% |
|---|---|
| Return on Assets | 2.09% |
| Return on Invested Capital | 2.76% |
Valuation & Multiples
| P/E Ratio | 60.22 |
|---|---|
| PEG | -5077.3 |
| Price to Sales | 5.24 |
| Price to Book Ratio | 1.75 |
| Enterprise Value to Revenue | 4.24 |
| Enterprise Value to EBIT | 51.7 |
| Enterprise Value to Net Income | 61 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Baotou Dongbao Bio-Tech Co.,Ltd
1,424 employees
CEO: Fang Liu Baotou Dongbao Bio-Tech Co., Ltd. specializes in the research, manufacturing, and global sales of gelatin and collagen products, serving both domestic and international markets. Their offerings include gelatin for food additives and phar...